VolitionRx (VNRX) Earnings Date, Estimates & Call Transcripts $0.66 -0.04 (-5.76%) (As of 09/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Earnings SummaryLatest Earnings DateAug. 14EstimatedActual EPS (Aug. 14) -$0.08 Beat By $0.01 Consensus EPS (Aug. 14) -$0.09 Get VolitionRx Earnings AlertsEnter your email address below to receive the latest news and earnings results for VNRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVNRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Brownstone ResearchIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.Just click here to register. VolitionRx Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.11)($0.11)($0.11)Q2 20241($0.09)($0.09)($0.09)Q3 20241($0.07)($0.07)($0.07)Q4 20241($0.05)($0.05)($0.05)FY 20244($0.32)($0.32)($0.32)VNRX Earnings Date and InformationVolitionRx last posted its earnings results on August 14th, 2024. The reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.01. The business earned $0.40 million during the quarter, compared to analyst estimates of $0.34 million. VolitionRx has generated ($0.46) earnings per share over the last year (($0.46) diluted earnings per share). Read More VolitionRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/14/2024Q2 2024($0.09)($0.08)+$0.01($0.08)$0.34 million$0.40 million5/13/2024Q1 2024($0.11)($0.10)+$0.01($0.10)$0.27 million$0.17 million 3/25/2024--($0.11)($0.11)($0.11)$0.50 million$0.24 million 11/14/2023Q3 2023($0.12)($0.11)+$0.01($0.11)$0.26 million$0.17 million 8/14/2023Q2 2023($0.13)($0.14)($0.01)($0.14)$0.29 million$0.22 million 5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million Get the Latest News and Ratings for VNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter. 3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million 11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million3/22/2021Q4 2020($0.10)($0.11)($0.01)($0.11)$1.13 million$0.01 million11/12/2020Q3 2020($0.11)($0.09)+$0.02($0.09)--8/13/2020Q2 2020($0.13)($0.12)+$0.01($0.12)-$0.01 million5/7/2020Q1 2020($0.10)($0.14)($0.04)($0.14)--2/20/2020Q4 2019($0.11)($0.09)+$0.02($0.09)--11/12/2019Q3 2019($0.11)($0.10)+$0.01($0.10)$0.06 million$0.02 million VolitionRx Earnings - Frequently Asked Questions When did VolitionRx announce their last quarterly earnings? VolitionRx (NYSE:VNRX) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on VNRX's earnings history. Did VolitionRx beat their earnings estimates last quarter? In the previous quarter, VolitionRx (NYSE:VNRX) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.09) by $0.01. Learn more on analysts' earnings estimate vs. VNRX's actual earnings. How much revenue does VolitionRx generate each year? VolitionRx (NYSE:VNRX) has a recorded annual revenue of $976,516.00. How much profit does VolitionRx generate each year? VolitionRx (NYSE:VNRX) has a recorded net income of -$35.32 million. VNRX has generated -$0.46 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: TSVT Earnings Results ADCT Earnings Results ELYM Earnings Results PROC Earnings Results INBX Earnings Results TRVI Earnings Results ZNTL Earnings Results PYXS Earnings Results GOSS Earnings Results CABA Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NYSE:VNRX) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredWall Street Insider Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VNRX Stock Alerts